awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38631019-35D09885-62BE-4472-9EB2-F18F66B0B9C5
Q38631019-35D09885-62BE-4472-9EB2-F18F66B0B9C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38631019-35D09885-62BE-4472-9EB2-F18F66B0B9C5
Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.
P2860
Q38631019-35D09885-62BE-4472-9EB2-F18F66B0B9C5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38631019-35D09885-62BE-4472-9EB2-F18F66B0B9C5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11cdd779bf7b26abb1ec7a7f2d1fd30111ae04a7
P2860
A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK-positive NSCLC but is sensitive to ceritinib.